As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
Everyone is waiting to see what CMS decides to do. Recently in the UK in London there are plans to open clinics just for this purpose and after the initial clinic more are to follow, so how we handle it in the US, everyone is waiting to see. BD September 9, 2008 | Payers, physicians, and...